Jefferies lowered its price target on Ultragenyx Pharma stock to $63 on the trial miss




Jefferies lowered its price target on Ultragenyx Pharma stock to $63 on the trial miss



Source link

  • Related Posts

    2 actions that could create lasting generational wealth

    These companies are making profits and cash. Microsoft has a historic business that takes advantage of the AI ​​revolution. Costco has a resilient membership model that helps it succeed where…

    HC Wainwright reiterated a Buy rating on Bright Minds stock with a $115 target

    HC Wainwright reiterated a Buy rating on Bright Minds stock with a $115 target Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *